Showing results (401-410 of 414) with videos related to

Sort By:
Pageof 42
Hepatology (Baltimore, Md.)|April 27, 2011
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis CJules L Dienstag, Marc G Ghany, Timothy R Morgan, et al.
Gastroenterology|August 12, 2019
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir TherapyAnna S Lok, Mark S Sulkowski, Jens J Kort, et al.
The American Journal of Gastroenterology|March 20, 2023
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter StudySimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
The American Journal of Gastroenterology|January 4, 2023
Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis BNorah A Terrault, Anna S Lok, Abdus S Wahed, et al.
The New England Journal of Medicine|January 17, 2014
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infectionMark S Sulkowski, David F Gardiner, Maribel Rodriguez-Torres, et al.
Antiviral Research|December 18, 2017
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshopTimothy M Block, Harvey Alter, Nathaniel Brown, et al.
Hepatology (Baltimore, Md.)|November 4, 2025
Technical systematic review supporting 2025 AASLD practice guidelines on management of chronic hepatitis BCalvin Q Pan, Samer Saadi, Marc G Ghany, et al.
JCI Insight|February 23, 2021
Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liverDaniel Traum, Yue J Wang, Kathleen B Schwarz, et al.
The American Journal of Gastroenterology|June 22, 2016
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE StudyJoseph Ahn, Joseph K Lim, Hannah M Lee, et al.
Hepatology (Baltimore, Md.)|July 13, 2021
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE StudyMark S Sulkowski, Juhi S Moon, Kenneth E Sherman, et al.
Pageof 42